pubmed-article:3128610 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:3128610 | lifeskim:mentions | umls-concept:C0005715 | lld:lifeskim |
pubmed-article:3128610 | lifeskim:mentions | umls-concept:C1622980 | lld:lifeskim |
pubmed-article:3128610 | lifeskim:mentions | umls-concept:C0085236 | lld:lifeskim |
pubmed-article:3128610 | lifeskim:mentions | umls-concept:C0162388 | lld:lifeskim |
pubmed-article:3128610 | lifeskim:mentions | umls-concept:C1533691 | lld:lifeskim |
pubmed-article:3128610 | lifeskim:mentions | umls-concept:C1879547 | lld:lifeskim |
pubmed-article:3128610 | lifeskim:mentions | umls-concept:C2349975 | lld:lifeskim |
pubmed-article:3128610 | lifeskim:mentions | umls-concept:C1515655 | lld:lifeskim |
pubmed-article:3128610 | pubmed:issue | 8 | lld:pubmed |
pubmed-article:3128610 | pubmed:dateCreated | 1988-5-18 | lld:pubmed |
pubmed-article:3128610 | pubmed:abstractText | The fungicidal capacity of murine pulmonary macrophages (PuM) activated in vitro with IFN or lymphokines or in vivo with IFN was studied. PuM treated overnight with IFN (1000 U/ml), Con A-stimulated spleen cell culture supernatants, or lymph node cells plus Con A significantly killed yeast cells of the Gar w isolate of Paracoccidioides brasiliensis 45.5 +/- 2.1%, 72.0 +/- 4.2%, and 51.5 +/- 0.7% respectively. Two other isolates of P. brasiliensis (Ru and LA) were also killed (45 and 34%) by PuM activated by lymph node cells plus Con A. Control PuM had lesser but significant capacity for killing of P. brasiliensis isolates, ranging from 15 to 22%. Killing of P. brasiliensis by PuM activated by Con A-stimulated spleen cell culture supernatants could not be significantly inhibited by superoxide dismutase, catalase, or azide. When mice were treated in vivo with 4 X 10(5) IFN U i.p. and PuM isolated 24 h later, the PuM had significantly enhanced ability to kill P. brasiliensis (47.0 +/- 6.3%) compared with PuM from control mice (25.0 +/- 4.2%). PuM thus activated also showed enhanced killing (43%) of a second isolate compared with control PuM (22%). PuM from IFN-treated mice were able to significantly kill Blastomyces dermatitidis (37.5 +/- 0.7%) compared with control PuM (4.5 +/- 6.3%). These results show that PuM can be activated in vitro and in vivo by IFN for enhanced fungicidal activity against two pulmonary fungal pathogens and suggests that immunologic production of IFN could be an important factor in host defenses against these diseases. | lld:pubmed |
pubmed-article:3128610 | pubmed:language | eng | lld:pubmed |
pubmed-article:3128610 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3128610 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:3128610 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3128610 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3128610 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3128610 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3128610 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:3128610 | pubmed:month | Apr | lld:pubmed |
pubmed-article:3128610 | pubmed:issn | 0022-1767 | lld:pubmed |
pubmed-article:3128610 | pubmed:author | pubmed-author:StevensD ADA | lld:pubmed |
pubmed-article:3128610 | pubmed:author | pubmed-author:RestrepoAA | lld:pubmed |
pubmed-article:3128610 | pubmed:author | pubmed-author:BrummerEE | lld:pubmed |
pubmed-article:3128610 | pubmed:author | pubmed-author:HansonL HLH | lld:pubmed |
pubmed-article:3128610 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:3128610 | pubmed:day | 15 | lld:pubmed |
pubmed-article:3128610 | pubmed:volume | 140 | lld:pubmed |
pubmed-article:3128610 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:3128610 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:3128610 | pubmed:pagination | 2786-9 | lld:pubmed |
pubmed-article:3128610 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
pubmed-article:3128610 | pubmed:meshHeading | pubmed-meshheading:3128610-... | lld:pubmed |
pubmed-article:3128610 | pubmed:meshHeading | pubmed-meshheading:3128610-... | lld:pubmed |
pubmed-article:3128610 | pubmed:meshHeading | pubmed-meshheading:3128610-... | lld:pubmed |
pubmed-article:3128610 | pubmed:meshHeading | pubmed-meshheading:3128610-... | lld:pubmed |
pubmed-article:3128610 | pubmed:meshHeading | pubmed-meshheading:3128610-... | lld:pubmed |
pubmed-article:3128610 | pubmed:meshHeading | pubmed-meshheading:3128610-... | lld:pubmed |
pubmed-article:3128610 | pubmed:meshHeading | pubmed-meshheading:3128610-... | lld:pubmed |
pubmed-article:3128610 | pubmed:meshHeading | pubmed-meshheading:3128610-... | lld:pubmed |
pubmed-article:3128610 | pubmed:meshHeading | pubmed-meshheading:3128610-... | lld:pubmed |
pubmed-article:3128610 | pubmed:meshHeading | pubmed-meshheading:3128610-... | lld:pubmed |
pubmed-article:3128610 | pubmed:meshHeading | pubmed-meshheading:3128610-... | lld:pubmed |
pubmed-article:3128610 | pubmed:meshHeading | pubmed-meshheading:3128610-... | lld:pubmed |
pubmed-article:3128610 | pubmed:meshHeading | pubmed-meshheading:3128610-... | lld:pubmed |
pubmed-article:3128610 | pubmed:meshHeading | pubmed-meshheading:3128610-... | lld:pubmed |
pubmed-article:3128610 | pubmed:year | 1988 | lld:pubmed |
pubmed-article:3128610 | pubmed:articleTitle | In vivo and in vitro activation of pulmonary macrophages by IFN-gamma for enhanced killing of Paracoccidioides brasiliensis or Blastomyces dermatitidis. | lld:pubmed |
pubmed-article:3128610 | pubmed:affiliation | Department of Medicine, Santa Clara Valley Medical Center, San Jose, CA 95128. | lld:pubmed |
pubmed-article:3128610 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:3128610 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
pubmed-article:3128610 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3128610 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3128610 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3128610 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3128610 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3128610 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3128610 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3128610 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3128610 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3128610 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3128610 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3128610 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3128610 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3128610 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3128610 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3128610 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3128610 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3128610 | lld:pubmed |